Sarah E. Gilpin

4.5k total citations · 2 hit papers
42 papers, 3.0k citations indexed

About

Sarah E. Gilpin is a scholar working on Surgery, Biomaterials and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah E. Gilpin has authored 42 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 21 papers in Biomaterials and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah E. Gilpin's work include Tissue Engineering and Regenerative Medicine (29 papers), Electrospun Nanofibers in Biomedical Applications (21 papers) and Neonatal Respiratory Health Research (8 papers). Sarah E. Gilpin is often cited by papers focused on Tissue Engineering and Regenerative Medicine (29 papers), Electrospun Nanofibers in Biomedical Applications (21 papers) and Neonatal Respiratory Health Research (8 papers). Sarah E. Gilpin collaborates with scholars based in United States, Canada and United Kingdom. Sarah E. Gilpin's co-authors include Harald C. Ott, Jacques P. Guyette, Gabriel González, Joseph P. Vacanti, Jeremy Song, Xi Ren, Douglas J. Mathisen, Jonathan M. Charest, Luis F. Tapias and Tatsuya Okamoto and has published in prestigious journals such as Nature Medicine, Nature Communications and Nature Biotechnology.

In The Last Decade

Sarah E. Gilpin

41 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regeneration and experimental orthotopic transplantation of a bioengineered kidney

2013 593 citations Jacques P. Guyette, Sarah E. Gilpin et al. profile →
Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip

2022 107 citations Haiqing Bai, Longlong Si et al. Nature Communications profile →

Peers

Countries citing papers authored by Sarah E. Gilpin

Since Specialization

Citations

This map shows the geographic impact of Sarah E. Gilpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Gilpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Gilpin more than expected).

Fields of papers citing papers by Sarah E. Gilpin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Gilpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Gilpin. The network helps show where Sarah E. Gilpin may publish in the future.

Co-authorship network of co-authors of Sarah E. Gilpin

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Gilpin. A scholar is included among the top collaborators of Sarah E. Gilpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Gilpin. Sarah E. Gilpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The molecular mechanisms of extracellular matrix-derived hydrogel therapy in idiopathic pulmonary fibrosis models 2023 ·Biomaterials ·(unknown), Ana Cláudia Oliveira Carreira, Milton Yutaka Nishiyama, Sarah E. Gilpin, María Angélica Miglino	11
2	Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip breakdown → 2022 ·Nature Communications ·Haiqing Bai, Longlong Si, Amanda Jiang, Chaitra Belgur, Yunhao Zhai, Roberto Plebani, Crystal Yuri Oh, Melissa Rodas, (unknown), Atiq Nurani, Sarah E. Gilpin, Rani K. Powers, Girija Goyal, Rachelle Prantil‐Baun, Donald E. Ingber	107
3	Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs 2022 ·Biomaterials ·Tong Wu, (unknown), William A. Michaud, (unknown), Sarah E. Gilpin, Mari Mino–Kenudson, Harald C. Ott	5
4	Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip 2021 ·Journal of Cystic Fibrosis ·Roberto Plebani, Ratnakar Potla, (unknown), Haiqing Bai, Zohreh Izadifar, Amanda Jiang, (unknown), Chaitra Belgur, (unknown), Mark Cartwright, Rachelle Prantil‐Baun, Pawan Jolly, Sarah E. Gilpin, Mario Romano, Donald E. Ingber	91
5	Protective Effects of Extracellular Matrix-Derived Hydrogels in Idiopathic Pulmonary Fibrosis 2021 ·Tissue Engineering Part B Reviews ·(unknown), Ana Cláudia Oliveira Carreira, Sarah E. Gilpin, María Angélica Miglino	7
6	Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019 2020 ·ERJ Open Research ·Darcy E. Wagner, Laertis Ikonomou, Sarah E. Gilpin, Chelsea M. Magin, Fernanda Ferreira Cruz, Allison M. Greaney, Mattias Magnusson, Ya‐Wen Chen, Brian R. Davis, Kim Vanuytsel, Sara Rolandsson Enes, Anna Krasnodembskaya, Mareike Lehmann, Gunilla Westergren‐Thorsson, John Stegmayr, Hani N. Alsafadi, (unknown), Daniel J. Weiss, Amy L. Ryan	5
7	Technological advances in study of lung regenerative medicine:perspective from the 2019 Vermont lung stem cell conference 2020 ·Cytotherapy ·Laertis Ikonomou, Darcy E. Wagner, Sarah E. Gilpin, Daniel J. Weiss, Amy L. Ryan	6
8	Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report 2019 ·American Journal of Respiratory Cell and Molecular Biology ·Amy L. Ryan, Laertis Ikonomou, (unknown), Deniz A. Bölükbas, Jennifer J.P. Collins, Robert J. Freishtat, Finn Hawkins, Sarah E. Gilpin, Franziska E. Uhl, Juan J. Uriarte, Daniel J. Weiss, Darcy E. Wagner	12
9	Creation of Laryngeal Grafts from Primary Human Cells and Decellularized Laryngeal Scaffolds 2019 ·Tissue Engineering Part A ·Philipp T. Moser, M Gerli, Gillian R. Diercks, (unknown), Jonathan M. Charest, Joshua R. Gershlak, Xi Ren, Sarah E. Gilpin, Bernhard J. Jank, Glenn R. Gaudette, Christopher J. Hartnick, Harald C. Ott	14
10	A Fully Automated High-Throughput Bioreactor System for Lung Regeneration 2018 ·Tissue Engineering Part C Methods ·(unknown), Tong Wu, Sarah E. Gilpin, Harald C. Ott	10
11	Acellular human lung scaffolds to model lung disease and tissue regeneration 2018 ·European Respiratory Review ·Sarah E. Gilpin, Darcy E. Wagner	51
12	An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases 2016 ·Annals of the American Thoracic Society ·Darcy E. Wagner, Wellington V. Cardoso, Sarah E. Gilpin, Susan M. Majka, Harald C. Ott, Scott H. Randell, Bernard Thébaud, Thomas K. Waddell, Daniel J. Weiss	41
13	Regenerative potential of human airway stem cells in lung epithelial engineering 2016 ·Biomaterials ·Sarah E. Gilpin, Jonathan M. Charest, Xi Ren, Luis F. Tapias, Tong Wu, (unknown), Douglas J. Mathisen, Harald C. Ott	54
14	Using Nature’s Platform to Engineer Bio-Artificial Lungs 2015 ·Annals of the American Thoracic Society ·Sarah E. Gilpin, Harald C. Ott	37
15	Engineering pulmonary vasculature in decellularized rat and human lungs 2015 ·Nature Biotechnology ·Xi Ren, Philipp T. Moser, Sarah E. Gilpin, Tatsuya Okamoto, Tong Wu, Luis F. Tapias, François Mercier, Linjie Xiong, (unknown), David T. Scadden, Douglas J. Mathisen, Harald C. Ott	174
16	Assessment of Proliferation and Cytotoxicity in a Biomimetic Three-Dimensional Model of Lung Cancer 2015 ·The Annals of Thoracic Surgery ·Luis F. Tapias, Sarah E. Gilpin, Xi Ren, Lan Wei, Bryan C. Fuchs, Kenneth K. Tanabe, Michael Lanuti, Harald C. Ott	21
17	Enhanced Lung Epithelial Specification of Human Induced Pluripotent Stem Cells on Decellularized Lung Matrix 2014 ·The Annals of Thoracic Surgery ·Sarah E. Gilpin, Xi Ren, Tatsuya Okamoto, Jacques P. Guyette, Hongmei Mou, Jayaraj Rajagopal, Douglas J. Mathisen, Joseph P. Vacanti, Harald C. Ott	103
18	Altered progenitor cell and cytokine profiles in bronchiolitis obliterans syndrome 2012 ·The Journal of Heart and Lung Transplantation ·Sarah E. Gilpin, Kalvin Lung, Masaaki Sato, L.G. Singer, Shaf Keshavjee, Thomas K. Waddell	15
19	Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis 2009 ·American Journal of Respiratory and Critical Care Medicine ·Antje Moeller, Sarah E. Gilpin, Kjetil Ask, Gerard Cox, Deborah Cook, Jack Gauldie, Peter J. Margetts, László Farkas, Julian Dobranowski, Colm Boylan, Paul M. O’Byrne, Robert M. Strieter, Martin Kolb	377
20	Cell-specific Gene Expression in Patients with Usual Interstitial Pneumonia 2006 ·American Journal of Respiratory and Critical Care Medicine ·Margaret M. Kelly, Richard Leigh, Sarah E. Gilpin, (unknown), Gail Martin, Katherine Radford, Gerard Cox, Jack Gauldie	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact